Introducing the return of STAT’s Biotech Scorecard, our quarterly ledger of stock-moving biotech events.
We were prepared to let the scorecard die a natural death at the end of 2018, but then we heard from die-hard fans (and STAT Plus subscribers) asking for its return. We listen to our customers, so the scorecard is reborn.
You will notice one cosmetic change that we hope is not too disruptive. We’ve done away with the actual emoji-enhanced scorecard graphic. It was too time-consuming; plus, we were lousy about updating it in a timely fashion.
About the Author Reprints
